Slingshot members are tracking this event:
Amgen (AMGN) Announces Top-Line Results From Phase 3 KYPROLIS (Carfilzomib) CLARION Study In Newly Diagnosed Multiple Myeloma Patients
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
Slingshot Insights Explained
Sep 27, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Carfilzomib, Kyprolis, Multiple Myeloma Patients, Hematopoietic Stem-cell Transplant, Multiple Myeloma, Clarion Trial